Is Regeneron Pharmaceuticals, Inc. overvalued?

Regeneron Pharmaceuticals, Inc. (REGN) looks fairly valued — trading about 2% above its fair value.

Fairly valued

Price

$788.04

Fair value

$773.52

Current P/E

19.0

Normal P/E

18.6

Market cap

$81.19B

Dividend yield

0.5%

Return on equity

13.8%

Sector

Healthcare

Fair value compares REGN's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.

Related stocks